15
Views
8
CrossRef citations to date
0
Altmetric
Research Article

Emergence of Trimethoprim-resistant Escherichia coli in Healthy Persons in the Absence of Prophylactic or Therapeutic Antibiotics During Travel to Guadalajara, Mexico

Pages 812-814 | Published online: 08 Jul 2009

References

  • World Health Organization. The World Health Report 1996: Report of the Director-General. Geneva: World Health Organization, 1996.
  • Kean BH. Turista in Teheran. Lancet 1969; 2: 583–4.
  • Kendrick MA. Study of illness among Americans returning from international travel. J Infect Dis 1972; 126: 684–5.
  • Lowenstein MS, Balows A, Gangarosa EJ. Turista at an international congress in Mexico. Lancet 1973; i: 529–31.
  • Steffen R. Epidemiologic studies of traveler’s diarrhea, severe gastrointestinal infections and cholera. Rev Infect Dis 1986; 8 (Suppl 2): 122–30.
  • Kean BH. The diarrhea of travelers to Mexico: summary of a five-year study. Ann Intern Med 1963; 59: 605–14.
  • Steffen RF, Van de Linde KG, Van de Linde MS. Epidemiology of diarrhea in travelers. JAMA 1983; 249: 1176–80.
  • Pickering LK, DuPont HL, Evans DG, Evans DJ, Olarte J. Isolation of enteric pathogens from asymptomatic students from the United States and Latin America. J Infect Dis 1977; 135: 1003–5.
  • Murray BE, Rensimer ER, DuPont HL. Emergence of high level trimethoprim resistance in fecal Escherichia coli during oral administration of trimethoprim or trimethoprim sulfamethoxazole. N Engl J Med 1982; 306: 130–5.
  • Sack RB, Santosham M, Froehlick JL, Medina C, Orskov F, Orskov I. Doxycycline prophylaxis of travelers’ diarrhea in Honduras, an area where resistance to doxycycline is common among enterotoxigenic Escherichia coli. Am J Trop Med Hyg 1984; 33: 460–6.
  • Sanosham M, Sack RB, Froehlich J, Greenberg H, Yolken R, Kapikian A, et al. Biweekly prophylactic doxycycline for traveler’s diarrhea. J Infect Dis 1981; 143: 598–602.
  • Gray LD. Escherichia, Salmonella, Shigella, and Yersinia. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RM, eds. Manual of clinical microbiology. Washington, DC: ASM, 1995: 450–6.
  • DuPont HL, Olarte J, Evans DG, Pickering LK, Galindo E, Evans DJ. Comparative susceptibility of Latin American and United States students to enteric pathogens. N Engl J Med 1976; 295: 1520–1.
  • Bauer AW, Kirby WMM, Sherris JC, Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol 1966; 45: 493–6.
  • National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility tests. Approved standard M2-A6. Wayne, PA: National Committee for Clinical Laboratory Standards, 1997.
  • Barth P, Datta N, Hedges R, Grinter N. Transposition of a deoxyribose nucleic acid sequence encoding trimethoprim and streptomycin resistances from R483 to other replicons. J Bacteriol 1976; 125: 800–10.
  • Shapiro JA, Sporn P. Tn402: a new transposable element determining trimethoprim resistance that inserts in bacteriophage lambda. J Bacteriol 1977; 129: 1632–5.
  • Stenderup J, Orskov I, Orskov F. Changes in serotype and resistance pattern of the intestinal Escherichia coli flora during travel. Results from a trial of mecillinam as a prophylactic against travellers’ diarrhoea. Scand J Infect Dis 1983; 15: 367–73.
  • Gaarslev K, Stenderup J. Changes during travel in the composition and antibiotic resistance pattern of the intestinal Enterobacteriaceae flora: results from a study of mecillinam prophylaxis against travellers’ diarrhoea. Curr Med Res Opin 1985; 9: 384–7.
  • Wistrom J, Gentry LO, Palmgren AC, Price M, Nord CE, Ljungh A, et al. Ecological effects of short-term ciprofloxacin treatment of travellers’ diarrhoea. J Antimicrob Chemother 1992; 30: 693–706.
  • Wistrom J, Norrby SR, Burman LG, Lundholm R, Jellheden B, Englund G. Norfloxacin versus placebo for prophylaxis against travellers’ diarrhoea. J Antimicrob Chemother 1987; 20: 563–74.
  • Falkow S. Infectious drug resistance. London: Pion Limited, 1975: 58–75.
  • Mitsuhashi S. R-factor, drug resistance plasmid. Baltimore, MD: University Park Press, 1977: 3–37.
  • Rowe B, Threfall EJ. Drug resistance in gram negative aerobic bacilli. Br Med Bull 1984; 40: 68–76.
  • Tiemens KM, Shipley PL, Correia RA, Shields DS, Guerrant DL. Sulfamethoxazole-trimethoprim-resistant Shigella flexneri in northeastern Brazil. Antimicrob Agents Chemother 1984; 25: 653–4.
  • Wood LV, Jansen DR, DuPont HL. Antimicrobial resistance of gram-negative bacteria isolated from foods in Mexico. J Infect Dis 1983; 148: 766.
  • Johnson PC, Ericsson CD, Morgan DR, DuPont HL, Cabada FJ. Lack of emergence of resistant fecal flora during successful prophylaxis of traveler’s diarrhea with norfloxacin. Antimicrob Agents Chemother 1986; 30: 671–4.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.